Ann: Race Oncology Share Purchase Plan Opens, page-192

I see Dr T posting as a great opportunity to get further educated and interact on a more personal level.

Other companies should really take a page out of RAC's book for shareholder communication. It only leads to a more informed shareholder base which can only be beneficial for a company.

In a way it's a compliment that it's seen as "ramping"... It's a nod at the amazing potential of Zantrene if all Dr T has done is answer scientific based questions and other related questions about the company in such a public and transparent way, much better than answering emails for investor queries like many other companies do, everyone gets to learn our way

In saying this I will be doing whatever I can to scrape together funds to participate in this SPP... At $3 it's too good to turn down, plus money in the pockets of RAC to prove the unreal potential this drug has!

At 20 years old I still feel so lucky to have found such an amazing opportunity so young.